Amgen News
Most Popular Amgen Story
Deutsche analyst: Pfizer likely to bid for Amgen
Noted Deutsche Bank analyst Barbara Ryan says that Pfizer is likely to make a major play to establish itself in biotechnology, with a bid for Amgen likely. Discussing the challenges that pharma... Read more...
Latest Headlines
- December 22, 2008
- December 17, 2008
- December 9, 2008
- December 5, 2008
- November 20, 2008
- November 10, 2008
- November 7, 2008
- October 24, 2008
- September 28, 2008
- September 24, 2008
- September 16, 2008
- September 15, 2008
- August 25, 2008
- July 29, 2008
- July 28, 2008
- July 23, 2008
- July 22, 2008
- July 14, 2008
- July 8, 2008
- July 3, 2008
Paid Research Reports
- RNA therapy: the next big thing after monoclonal antibodies?
- Biotech M&A Strategies: Deal assessments, trends and future prospects
- The Dermatology Market Outlook to 2013: Competitive landscape, pipeline analysis and growth opportunities
- Pipeline Insight: Cancer Overview - Breast, Gynecological, Genitourinary - Diverse drugs approaching the market for many tumor t
- Sales Force Effectiveness
- Forecast Model: Antidyslipidemics - Genericization and negative trial data drive market shrinkage
